Tuesday, Apr 9, 2024 · SEC filings

What the smart money revealed on Apr 9

Real insider buys18insiders · $3.64M
Real insider sales32insiders · $81.3M
Fund 13Fs filed—not loaded for this day
Activist 13Ds filed—not loaded for this day

309 insider filings came in. We hid 45 planned (10b5-1) sellers and 206 people whose filings were routine, like grants and tax withholding.

group

6 insiders at Pagaya Technologies (PGY) bought $2.01M of stock

Roles: CEO, President, CTO, Chief People Officer, Chief Revenue Officer, Director. Several insiders buying in the same few days is rare.

Cluster buy Form 4 Traded Apr 3–5
$2.01M
trending_up

Flora Growth (ZSTK) CEO Clifford Starke bought $1M

526,315 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Apr 8
$1M
trending_up

BRT Apartments (BRT) President and CEO Jeffrey Gould bought $207K

12,299 shares on the open market. Not a grant or an option exercise. Their past buys: 1 of 5 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 1 of 5 beat Traded Apr 5
$207K
trending_up

BRT Apartments (BRT) Senior Vice President Matthew Gould bought $207K

12,299 shares on the open market. Not a grant or an option exercise. Their past buys: 1 of 5 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 1 of 5 beat Traded Apr 4
$207K
trending_up

GameStop (GME) Director Lawrence Cheng bought $112K

10,000 shares on the open market. Not a grant or an option exercise. Their past buys: 3 of 4 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 3 of 4 beat Traded Apr 8
$112K
trending_down

FedEx (FDX) Executive Chairman Frederick Smith sold $31.1M

Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 14.51M shares directly.

Real sale Form 4 Traded Apr 9
$31.1M
trending_down

NVIDIA (NVDA) Director Mark Stevens sold $20M

Not marked as a planned 10b5-1 sale. Sold 2% of the shares they held directly. Still holds 1.05M shares.

Real sale Form 4 Traded Apr 5
$20M
trending_down

HCI Group (HCI) Division President Anthony Saravanos sold $2.8M

Not marked as a planned 10b5-1 sale. Sold 44% of the shares they held directly. Still holds 30,000 shares.

Real sale Form 4 Sold 44% of stake Traded Apr 5–8
$2.8M
Show 8 more real buys
Show 29 more real sales
GES Guess · CEO Carlos Alberini · Traded Apr 5–8
$10.6M
AVGO Broadcom · CFO and Chief Accounting Officer Kirsten Spears · Traded Apr 5
$4.03M
SNX TD SYNNEX · Head of Hyve Solutions Dennis Polk · Traded Apr 8
$2.36M
P Pure Storage · Chief Product Officer Ajay Singh · Traded Apr 5
$2.01M
TEAM Atlassian · Co-CEO Scott Farquhar · Traded Apr 8
$1.63M
LBRDA Liberty Broadband · Director J. David Wargo · Traded Apr 5–8
$1.29M
PATH UiPath · CFO Ashim Gupta · Traded Apr 4
$1.21M
TEAM Atlassian · Co-CEO Michael Cannon-Brookes · Traded Apr 8
$746K
NCNO nCino · Director William Ruh · Traded Apr 5–8
$517K
ACAD Acadia Pharmaceuticals · CEO Stephen Davis · Traded Apr 8
$475K
CNNE Cannae · CEO Richard Massey · Traded Apr 5
$474K
IAS Integral Ad Science Holding · CEO Lisa Utzschneider · Traded Apr 8
$306K
REX Rex American Resources · Executive COB Stuart Rose · Traded Apr 8
$290K
SNDA Sonida Senior Living · SVP - Chief Revenue Officer Michael Fryar · Traded Apr 8–9
$259K
PUBM PubMatic · CFO Steven Pantelick · Traded Apr 8
$210K
DRI Darden Restaurants · Director William Simon · Traded Apr 8
$193K
IAS Integral Ad Science Holding · CFO Tania Secor · Traded Apr 8
$181K
BRC Brady · Director Elizabeth Bruno · Traded Apr 8
$145K
MDT Medtronic · EVP and President Michael Marinaro · Traded Apr 8
$71K
CTGO Contango ORE · Director Joseph Compofelice · Traded Apr 9
$60.2K
JILL J.Jill · Director Jyothi Rao · Traded Apr 5
$52.2K
ACAD Acadia Pharmaceuticals · EVP Mark Schneyer · Traded Apr 8
$48.5K
ACAD Acadia Pharmaceuticals · EVP Brendan Teehan · Traded Apr 8
$45.9K
OABI OmniAb · Chief Legal Officer Charles Berkman · Traded Apr 8
$36.6K
OABI OmniAb · Executive VP Kurt Gustafson · Traded Apr 8
$36.6K
ACAD Acadia Pharmaceuticals · Principal Accounting Officer James Kihara · Traded Apr 8
$32K
JILL J.Jill · Director Shelley Milano · Traded Apr 9
$27.7K
TVRD Cara Therapeutics · Chief Medical Officer Joana Goncalves · Traded Apr 5
$2.28K
TVRD Cara Therapeutics · Sec'y Scott Terrillion · Traded Apr 5
$2.28K

13F season

Holdings as of Mar 31, 2024 are due May 15

50 funds have filed so far. 49 filed for the quarter before.

Biggest real insider buys, Apr 3–9

Open-market buys by officers and directors, filed in the 7 days up to Apr 9.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist